Загрузка...
Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis
Introduction: Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS. Evidence suggests that MS should be treated as early as possible in order to maximize the benefit of treatment. Areas covered: This review details current understanding about the treatment of relapsing–remitti...
Сохранить в:
Главный автор: | |
---|---|
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
Taylor & Francis
2014
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4133962/ https://ncbi.nlm.nih.gov/pubmed/24965353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2014.924496 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|